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ABSTRACT
Objectives To develop an assessment and recognition 
tool to identify elite athletes at risk for mental health 
symptoms and disorders.
Methods We conducted narrative and systematic 
reviews about mental health symptoms and disorders 
in active and former elite athletes. The views of active 
and former elite athletes (N=360) on mental health 
symptoms in elite sports were retrieved through an 
electronic questionnaire. Our group identified the 
objective(s), target group(s) and approach of the mental 
health tools. For the assessment tool, we undertook a 
modified Delphi consensus process and used existing 
validated screening instruments. Both tools were 
compiled during two 2- day meeting. We also explored 
the appropriateness and preliminary reliability and 
validity of the assessment tool.
Sport Mental Health Assessment Tool 1 and 
Sport Mental Health Recognition Tool 1 The 
International Olympic Committee Sport Mental Health 
Assessment Tool 1 (SMHAT-1) was developed for sports 
medicine physicians and other licensed/registered 
health professionals to assess elite athletes (defined 
as professional, Olympic, Paralympic or collegiate level; 
aged 16 years and older) potentially at risk for or already 
experiencing mental health symptoms and disorders. The 
SMHAT-1 consists of: (i) triage with an athlete- specific 
screening tool, (ii) six subsequent disorder- specific 
screening tools and (iii) a clinical assessment (and related 
management) by a sports medicine physician or licensed/
registered mental health professional (eg, psychiatrist 
and psychologist). The International Olympic Committee 
Sport Mental Health Recognition Tool 1 (SMHRT-1) was 
developed for athletes and their entourage (eg, friends, 
fellow athletes, family and coaches).
Conclusion The SMHAT-1 and SMHRT-1 enable that 
mental health symptoms and disorders in elite athletes 
are recognised earlier than they otherwise would. These 
tools should facilitate the timely referral of those athletes 
in need for appropriate support and treatment.
INTRODUCTION
Mental health symptoms and disorders include those 
involving anxiety, depression or substance misuse.1 
Their prevalence in elite athletes is substantial, and 
similar to their prevalence in the general population. 
It ranges from 19% for alcohol misuse to 34% for 
anxiety/depression for active elite athletes and from 
16% for distress to 26% for anxiety/depression for 
former elite athletes.1 During an elite sport career, 
generic and sport- specific stressors might increase 
the risk of mental health symptoms and disor-
ders.2–4 Adverse life events, severe musculoskeletal 
injuries and related surgeries with long recovery 
periods are associated with mental health symptoms 
and disorders.2–4 Transitioning out of elite sport is 
also difficult for many former athletes.2–4
In 2017, the International Olympic Committee 
(IOC) selected an international expert panel 
comprising 27 individuals to thoroughly review the 
available scientific literature regarding mental health 
symptoms and disorders among active and former 
elite athletes (professional, Olympic or collegiate 
level). These 27 experts were invited by the IOC to 
a 2.5- day consensus meeting in November 2018 in 
Lausanne, Switzerland. Scientific and clinical find-
ings were presented and discussed, ultimately leading 
to the International Olympic Committee consensus 
statement on mental health in elite athletes.5 One 
of the main recommendations embedded in the 
IOC consensus statement was the need to appro-
priately screen for mental health symptoms and 
disorders in elite athletes throughout their career 
to ensure that affected athletes ultimately receive 
the support and treatment they need.5 Following 
the consensus meeting, the IOC established the 
Mental Health Working Group (MHWG) with 11 
international experts (10 of whom were involved 
in the IOC consensus statement) aiming in part to 
develop an assessment and recognition tool for the 
early identification of elite athletes potentially at 
risk for experiencing mental health symptoms and 
disorders. This article describes the evidence- based 
and practice- based development of the tools. It also 
presents the preliminary reliability and validity, 
utility and feasibility of the assessment tool.
METHODS
We applied the Intervention Mapping and Knowl-
edge Transfer Scheme to develop the assess-
ment and recognition tool.6–10 We undertook the 
following steps: (A) reviewing the scientific liter-
ature on mental health symptoms and disorders 
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in elite athletes; (B) assessing the views of active and former 
elite athletes (inclusive of members of the athletes’ entourage) 
regarding mental health symptoms and disorders; (C) formu-
lating the objective(s), target group(s) and approach of the tools; 
(D) selecting the content of the tools and their development; and 
(E) assessing the appropriateness and preliminary reliability and 
validity of the assessment tool.
Step A: Review of the scientific literature
Authors of the IOC consensus statement conducted narra-
tive and systematic reviews regarding the prevalence, diag-
nosis, screening, treatment and management of mental health 
symptoms and disorders in elite sports. Search strategies were 
applied in relevant electronic databases (eg, PubMed, Sport-
Discus, PSycINFO, Scopus and Cochrane) for articles published 
in November 2018, utilising predefined eligibility criteria. Data 
from the included articles were extracted within standardised 
extraction forms and risk of bias of the included studies was 
described. When applicable, meta- analyses were performed, and 
pooled estimates were calculated.
Step B: Views of active and former elite athletes (including 
members of the athletes’ entourage)
We gathered the views of active and former elite athletes, inclu-
sive of their entourage, on concepts related to mental health 
symptoms and disorders in elite athletes via a short electronic 
questionnaire (Mentimeter, Stockholm, Sweden) at (i) the IOC 
International Athletes’ Forum (April 2019, Lausanne, Swit-
zerland) and (ii) the International Paralympic Committee’s 
Athletes’ Forum (November 2019, Colorado Springs, USA). The 
attendees (N=360) were either (i) active and former elite athletes 
(as members of National Olympic Committee and National 
Paralympic Committee athletes’ commissions), (ii) coaches in 
elite sports or (iii) representatives of sport governing bodies. The 
IOC MHWG submitted six questions and statements in English 
(sole language of these forums) to the audience as follows:
1. What is the first word that comes to your mind when you 
hear the words ‘mental health symptoms’?
2. Which is the first group you turn to when you feel low?
3. Who is most important to the protection of athletes’ mental 
health?
4. In elite sports, no one wants to talk about mental health 
problems (scored on 5- point scale, from ‘strongly disagree’ 
to ‘strongly agree’).
5. There is no recognition of mental health problems in my 
sport (scored on 5- point scale, from ‘strongly disagree’ to 
‘Strongly agree’).
6. There should be routine screenings for mental health prob-
lems by medical staff in my sport (‘yes’ or ‘no’).
The IOC Medical and Scientific Committee provided institu-
tional approval. Descriptive analyses (frequency) were conducted 
with the answers to these questions and statements.
Step C: Objective(s), target group(s) and approach
During a 2- day meeting of the IOC MHWG in April 2019 in 
Lausanne (Switzerland), we defined the objective(s), target 
group(s) and approach of the tools. Participants of the meeting 
were international experts with specialised training, skills and 
experience in a wide range of relevant domains, including but 
not limited to psychiatry, sports medicine, psychometrics and 
elite sport itself. We combined the information gathered from 
the scientific literature (step A) with the view of elite athletes 
and their entourage (step B), and relied on existing mental health 
screening and awareness tools used in sports for other domains 
such as concussion, harassment and abuse and relative energy 
deficiency in sport.11–13
Step D: Content and development
We selected the content and design of the tools during two 2- day 
meeting of the IOC MHWG held in Lausanne (Switzerland) in 
April and June 2019 (see step C). First, we considered the repro-
ducibility, validity, practicality (ie, assessment time), use and 
applicability of existing screening instruments in the context of 
elite sports. Next, 15 independent experts gauged the appropri-
ateness of the selected existing screening instruments through an 
expert rating process (ethical approval provided by the Univer-
sity of Washington’s Institutional Review Board). These experts 
were either (1) authors of the International Olympic Committee 
consensus statement on mental health in elite athletes and related 
specific narrative and systematic reviews of the scientific litera-
ture (see step A) or (2) licensed mental health professionals who 
are members of the Big Sky Sport Psychology Group and/or the 
Collegiate Clinical/Counselling Sport Psychology Association. 
Via an anonymous online survey, these experts were asked to 
indicate the extent to which they disagreed or agreed with the 
selection of the screening instruments on a 5- point Likert scale 
(from ‘1’ as ‘strongly disagree’ to ‘5’ as ‘strongly agree’).
Next, we conducted a modified Delphi consensus process to 
evaluate a provisional version of the assessment tool (ethical 
approval provided by the University of Washington’s Institu-
tional Review Board).14–19 Via an anonymous online survey, 
the experts were asked to provide quantitative and qualitative 
feedback on the seven components in this provisional version 
(introductory text and the six components labelled as ‘Action’). 
The online survey contained an embedded screenshot of the 
specific tool component on which feedback was being elicited, 
followed by two questions: (i) how clinically useful is the specific 
component and (ii) how feasible is the specific component for 
its application in elite sport settings. Each question was scored 
on a 9- point scale (from ‘1’ for ‘not useful/feasible’ to ‘9’ for 
‘extremely useful/feasible’) with the opportunity for open- ended 
written feedback.20 Descriptive statistics for both questions were 
calculated for each specific tool component, and open- ended 
feedback was compiled. A priori thresholds for component- level 
consensus were set as (1) mean score of greater than 7, (2) at least 
70% of respondents with a score of greater than 7 and (3) a coef-
ficient of variation (CV) of less than 0.50.20–22 The IOC MHWG 
and Delphi process facilitator (EK) reviewed and synthetised the 
results of the first round of Delphi voting, including reviewing 
open- ended participant comments to identify emergent themes 
related to lack of participant- rated utility or feasibility.23
Tool components meeting a priori thresholds for both useful-
ness and feasibility were not modified. Tool components not 
reaching numeric consensus thresholds were discussed, with a 
focus on themes emergent from the qualitative participant feed-
back.24 Following modifications, these steps were repeated.
Step E: Appropriateness and preliminary reliability and 
validity
We explored (i) the appropriateness of the assessment tool 
among sport medicine physicians and (ii) its preliminary reli-
ability and validity among professional footballers.
Sport medicine physicians (N=43) participating in the Interna-
tional Federations Medical Commission Chairpersons Meeting 
(March 2020, Monaco; institutional approval provided by the 
IOC Medical and Scientific Committee) were asked to assess 
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the appropriateness of the assessment tool following applica-
tion to two hypothetical cases. Their evaluation was collected 
electronically (Mentimeter, Stockholm, Sweden) through eight 
statements (eg, ‘The tool will be useful for health professionals 
working in the context of elite sports’) rated on a 4- point scale 
(strongly disagree, disagree, agree and strongly agree). Partici-
pants also provided qualitative feedback .
The preliminary reliability and validity of the screening instru-
ments selected for the assessment tool were evaluated through an 
observational study based on a cross- sectional design conducted 
among male- identified and female- identified professional 
footballers from Australian A- League and W- League (ethical 
approval provided by the Medical Ethics Review Committee 
of the Amsterdam University Medical Centers, location AMC; 
W18_340#18.387). Participants (men: N=149, mean age: 24 
years, mean career duration: 6 years; women: N=132, mean age: 
23 years, mean career duration: 5 years) were asked to complete 
the screening instruments for the tool, in addition to the vali-
dated Kessler Distress questionnaire (K10).25 Internal consis-
tency (degree of inter- relatedness among items) of each screening 
instrument was ascertained, being expressed with Cronbach’s 
alpha (α≥0.70 considered as good; 0.60 < α<0.70 considered 
as moderate; r≤0.59 considered as low and thresholds lower 
with fewer items).26 When applicable, convergent validity with 
K10 was calculated and expressed with Pearson correlation coef-
ficients (r≥0.60 considered as good; 0.60<r < 0.30 considered 
as moderate and r≤0.30 considered as low) while a series of area 
under receiver operating characteristic curves was undertaken 
to evaluate the existing cut- off scores relative to the K10 cut- 
off scores for moderate distress (K10 ≥16), high distress (K10 
≥22) and very high distress (K10 ≥30) separately (AUC ≥0.90 
considered as very good; AUC ≥0.80 considered as good and 
AUC ≥0.70 considered as fair).26 27 Analysis of misclassification 
(false negative rate) between selected screening instruments was 
also undertaken.
Patient and public involvement
Active and former elite athletes, inclusive of their entou-
rage (eg, athletes’ representatives, coaches, representatives 
of governing bodies and sports medicine physicians), were 
involved in developing the tool and assessing its validation and 
appropriateness.
RESULTS
Step A: Reviewing the scientific literature
In total, 14 689 citations were identified and screened by the 
international experts, leading ultimately to the International 
Olympic Committee consensus statement on mental health in 
elite athletes and 11 related publications.1 5 28–37 All available 
evidence was published in two issues of the British Journal of 
Sports Medicine.
Step B: View of active and former elite athletes (including 
entourage)
The participants in the IOC International Athletes’ Forum 
associated a wide range of words with the term ‘mental health 
symptoms’ (figure 1). Nearly 55% of respondents mentioned the 
word ‘depression’, 33% the word ‘stress’, and 20% the words 
‘anxiety’ or ‘pressure’. They reported that they would approach 
friends and fellow athletes (50%), family (40%) and coaches 
(8%) when experiencing mental health symptoms. Participants 
identified coaches (55%), parents and friends (25%) and medical 
team (9%) as important facilitators of athletes’ mental health. 
Nearly two- thirds of the participants agreed that talking about 
mental health symptoms was taboo in elite sports and that there 
was no recognition of these symptoms in their sport. Ninety per 
cent were in favour of routine screenings by the medical team for 
mental health symptoms in their sport.
Figure 1 Word cloud of the view of athletes (including entourage) about mental health symptoms.
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Step C: Objective(s), target group(s) and approach
Based on steps A and B, the IOC MHWG formulated the 
following objective for the assessment tool: to assess elite athletes 
(defined as professional, Olympic, Paralympic or collegiate level; 
aged 16 years and older) potentially at risk for (ie, exposed to 
one or more stressors), or already experiencing, mental health 
symptoms and disorders to facilitate timely management and/
or referral to adequate support and/or treatment. We established 
that the assessment tool should be used only by sports medicine 
physicians and other licensed/registered health professionals, 
and we defined a three- step approach (step 1: triage; step 2: 
screening and step 3: intervention and (re)assessment).
Step D: Content and development
We selected an existing validated screening instrument (avail-
able freely in the public domain) for the triage step (step 1) and 
six existing validated screening instruments (available freely in 
the public domain), related to the most prevalent mental health 
symptoms in elite sports, for the screening step (step 2).1 5 
Combined with a final section on intervention and r(e)assess-
ment (step 3), we developed a provisional version of the assess-
ment tool called the IOC Sport Mental Health Assessment Tool 
(SMHAT).
Each of the screening tools included in the SMHAT were 
rated as ‘appropriate’ or ‘very appropriate’ (scores of 4 or 5 on a 
5- point scale) by more than 73% of experts, and five of the seven 
had mean scores of >4.00. The two lowest scoring scales were 
athlete distress, as measured by the Athlete Psychological Strain 
Questionnaire (APSQ: mean=3.80, SD=1.15, 73% ‘appro-
priate’ or ‘very appropriate’), and depression, as measured by 
the Patient Health Questionnaire-9 (PHQ-9) (mean=3.93, 
SD=1.33, 80% ‘appropriate’ or ‘very appropriate’). Despite the 
expressed concerns about the APSQ’s sensitivity and specificity 
in identifying athletes who require further screening, the IOC 
MHWG elected to retain this measure because evidence about 
the APSQ’s psychometrics was imminently to be published.37 38 
Concern was also expressed about the utility of the PHQ-9 to 
measure more subtle subclinical issues. The IOC MHWG elected 
to retain the PHQ-9 because it is one of the commonly used 
instruments in the context of elite sports which has been vali-
dated across different cultures and languages.
In the first round of the Delphi consensus process, one compo-
nent that did not meet a priori thresholds for both utility and 
feasibility was ‘step 3b’ (clinical assessment and management, 
mean utility score=6.87, SD=2.23, 67%>7, CV=32.50; mean 
feasibility score=6.93, SD=1.28, 73%>7, CV=18.46). There 
were concerns about the required expertise for this step. No 
alteration to this component was made because the IOC MHWG 
strongly believed that sport medicine physicians working with 
elite athletes should have sufficient competency to conduct a 
clinical assessment and define a management plan. Two other 
components did not meet thresholds for consensus feasibility. 
The introduction (mean=6.60, SD=1.40, 53%>7, CV=21.27) 
was described as being too long and difficult to read in the 
context of clinical practice. In response, the IOC MHWG edited 
this section to streamline and facilitate understanding. Concerns 
were also expressed about the additional screening tools for 
mental health symptoms and disorders (mean=6.60, SD=2.03, 
67%>7, CV=30.73). The IOC MHWG elected to not change 
this section because these additional screening tools are not 
mandatory and are only suggestions for clinicians to consider.
The revised SMHAT was shared with the same pool of experts 
for an additional round of rating on the two edited components. 
Utility and feasibility of the edited introduction exceeded 
consensus thresholds. Utility of step 3b (clinical assessment and 
management) also exceeded consensus thresholds (mean=8.14, 
SD=1.21, 85.71%>7, CV=14.92), while feasibility did not 
exceed the threshold (mean=6.71, SD=2.06, 71.43%>7, 
CV=30.66). Feasibility concerns for this section continued to 
relate to the level of training of the person making this assess-
ment. The IOC MHWG elected to leave this component unal-
tered, in recognition of the challenge of having access to licensed 
mental health professionals in sport settings.5 Another consider-
ation is that we developed a separate tool to facilitate recogni-
tion and triage of mental health concerns for use by non- clinical 
personnel.
The Sport Mental Health Assessment Tool 1
Based on three steps (figure 2), the SMHAT-1 (first version; 
intended to be updated in the future) allows for early stage iden-
tification of those athletes in need of mental health treatment. 
The SMHAT-1 can be used by sports medicine physicians and 
other licensed/registered health professionals, but the clinical 
assessment (and related management) within the SMHAT-1 (see 
step 3b) must be conducted by sport medicine physicians and/
or licensed/registered mental health professionals, including 
clinically trained sport psychologists. Physical therapists, athletic 
trainers and not clinically trained sport psychologists working 
with a sports medicine physician can use the SMHAT-1, but any 
guidance or intervention should remain the responsibility of 
their sports medicine physician.
Step 1: triage
The APSQ assesses sport- related psychological distress and is 
used for a first triage.38 The APSQ is a brief, self- report rating 
scale specific to the sport context and relying on 10 items (eg, 
‘During the past 4 weeks, I could not stop worrying about injury 
or my performance’) scored on a 5- point scale (from ‘none of 
the time’ (1) to ‘all of the time’ (5)).37 A total score ranging from 
10 to 50 is calculated by summing the answers on the 10 items, 
with a score of 17 or more indicating an elevated or high risk for 
psychological distress.38 39 The APSQ has been validated in male 
and female athletes (area under curve value >0.90).38 39 In case 
of a negative triage, no further action is needed, while a positive 
triage leads to the subsequent step (step 2: Screening).
Step 2: screening
In case of a positive triage, athletes proceed to step 2 and are 
assessed on six disorder- specific screening questionnaires:
 ► General Anxiety Disorder-7 (GAD-7): assesses the presence 
of symptoms of anxiety.40
 ► Patient Health Questionnaire-9 (PHQ-9): assesses the pres-
ence of symptoms of depression.41 42
 ► Athlete Sleep Screening Questionnaire (ASSQ): assesses the 
presence of sleep disturbance.43–45
 ► Alcohol Use Disorders Identification Test Consumption 
(AUDIT- C): assesses the presence of alcohol misuse.46–48
 ► Cutting Down, Annoyance by Criticism, Guilty Feeling, 
and Eye- openers Adapted to Include Drugs (CAGE- AID): 
assesses the presence of substance misuse, being slightly 
adapted for the SMHAT (no focus on alcohol use as already 
explored with the AUDIT- C; additional question to explore 
which substance was used).49–54
 ► Brief Eating Disorder in Athletes Questionnaire (BEDA- Q): 
assesses the presence of disordered eating.55
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Further information about these existing validated screening 
questionnaires (including psychometric properties) is presented 
in online supplementary material. If all screening questionnaires 
are negative, the administrator proceeds to step 3a (brief inter-
vention and monitoring, given the report of elevated psycho-
logical distress at step 1: triage). If one or more screening 
questionnaires are positive (or if a positive answer is given on 
item 9 of the PHQ-9), the administrator proceeds to step 3b 
(clinical assessment and management).
Step 3a: brief intervention and monitoring
Based on the athlete’s history/record and on the information 
provided in steps 1 and 2, the administrator might refer the 
athlete to a brief intervention such as psychoeducation, mind-
fulness, meditation, mental skills training or stress control. 
Depending on the progress of the athlete and after the comple-
tion of the brief intervention(s), the administrator should 
consider readministering the APSQ. In the case of a negative 
APSQ, no further action is needed, while another positive APSQ 
leads to step 3b (assessment and management).
Step 3b: clinical assessment and management
Considering the previous outcomes (steps 1 and 2), a compre-
hensive clinical assessment is conducted by a sport medicine 
physician and/or licensed/registered mental health professional 
(eg, psychiatrist and clinical psychologist) to obtain additional 
relevant information (eg, mental health history, history of and/
or presence of harassment/abuse within or outside of sports) and 
ultimately to identify a clinical diagnosis. For each of these diag-
noses, severity and complexity, as well as diagnostic uncertainty 
and previous treatment non- response, are assessed. If the sports 
medicine physician does not feel comfortable determining the 
severity and/or complexity of a given athlete’s diagnosis, then 
referral to a licensed/registered mental health professional may 
be made. Based on all available information, the sport medicine 
physician and/or licensed/registered mental health professional 
chooses one of the following three actions:
1. In cases that are neither severe nor complex and where 
there is no diagnostic uncertainty nor history of previous 
non- responsive to treatment, then treatment/support can 
be provided by a sports medicine/primary care physician. 
The physician should refer to the International Olympic 
Committee consensus statement on mental health in elite 
athletes for specific guidance on treatment modalities.5
2. In cases of diagnostic uncertainty or when further informa-
tion might be useful, additional screening questionnaires for 
other mental health symptoms and disorders, including but 
not limited to attention- deficit/hyperactivity disorder, bipo-
lar disorder, post- traumatic stress disorder, gambling disor-
der and/or psychosis, can be considered prior to definitive 
diagnosis and the creation of a management/intervention 
plan.56–66
3. In cases that are severe, complex, diagnostically uncertain 
even after additional screening is completed and/or non- 
responsive to treatment, we recommend referral of the ath-
lete to a licensed/registered mental health professional (eg, 
clinical psychologist or psychiatrist).
The SMHAT-1 should be embedded within the precompetition 
period (ie, ideally a few weeks after the start of sport training), 
as well as within the mid- season and end- season period. The 
SMHAT-1 can also be used when the athlete experiences any 
significant life event such as major injury/illness, surgery, unex-
plained performance concern, suspected harassment/abuse, 
after a major competition, at the end of a competitive cycle, or 
when transitioning out of sport. The SMHAT-1 is available as a 
paper version (online supplementary appendix); however, the 
triage and screening (steps 1 and 2) are designed to be ideally 
embedded in a privacy- secured online platform. The SMHAT-1 
can be freely copied in its current form for distribution to indi-
viduals, teams, groups and organisations. Any revision requires 
the approval by the IOC MHWG. To strengthen its multicultural 
use, we encourage the translation of the SMHAT-1 in collab-
oration with the IOC MHWG. The SMHAT-1 should not be 
re- branded or sold for commercial gain.
Figure 2 Flow chart of the International Olympic Committee Sport Mental Health Assessment Tool 1.
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The Sport Mental Health Recognition Tool 1
Since the athletes’ entourage (eg, friends, fellow athletes, family 
and coaches) were identified as essential supports for athletes 
mental health (see step 3b), the IOC MHWG developed the 
IOC Sport Mental Health Recognition Tool 1 (SMHRT-1, 
first version; intended to be updated in the future), a recogni-
tion tool to be used by athletes coaches, family members and 
all other members of the athlete’s entourage. The objective of 
the SMHRT-1 is to facilitate early detection of mental health 
symptoms in elite athletes (professional, Olympic, Paralympic 
or collegiate level; aged 16 years and older) to promote help- 
seeking for those athletes in need of assistance from a sports 
medicine physician or other licensed/registered health profes-
sional and to facilitate further assessment and subsequent treat-
ment as applicable.
The SMHRT-1 relies on the observation of significant and/or 
persistent thoughts, feelings, behaviours and/or physical changes 
in athletes. In cases where those are observed, the athletes should 
be directed to a sports medicine physician or licensed/regis-
tered health professional for mental health screening with the 
SMHAT-1. Within the SMHRT-1, several items constituting red 
flags were also identified (eg, comments related to harming self 
or others), which warrant immediate help- seeking and possible 
crisis management. The SMHRT-1 is available in paper format 
(online supplementary appendix) and can be freely copied in its 
current form for distribution to individuals, teams, groups and 
organisations. Any revision requires the specific approval by the 
IOC MHWG while any translation should be reported to the 
IOC MHWG. The SMHRT-1 should not be rebranded or sold 
for commercial gain.
Step E: Appropriateness and preliminary reliability and 
validity
More than 90% of participants in the International Federations 
Medical Commission Chairpersons Meeting agreed that the 
SMHAT-1 would be useful for sports medicine physicians and 
other licensed/registered health professionals working in the 
context of elite sports. Around 55% of respondents were posi-
tive about the ease of use of the SMHAT-1, mentioning espe-
cially that translation in different languages is needed. Nearly 
90% stated that the three- step approach of the SMHAT-1 was 
appropriate, while each single step was also assessed positively: 
93% for step 1 (triage); 100% for step 2 (screening); 85% for 
step 3a (brief intervention); 83% for step 3b (clinical assess-
ment); 63% for additional screening in step 3b.
Internal consistency was moderate to good for the APSQ 
(men: α=0.81; women: α=0.84), GAD-7 (men: α=0.91; 
women: α=0.88), PHQ-9 (men: α=0.87; women: α=0.83), 
ASSQ (men: α=0.72; women: α=0.67), AUDIT- C (men: 
α=0.74; women: α=0.66) and CAGE- AID (men: α=0.69; 
women: α=0.66). Internal consistency was low for the BEDA- Q 
(men: α=0.59; women: α=0.66). Convergent validity between 
APSQ and K10 was good to very good in both male- identified 
and female- identified professional footballers (r=0.70–0.73, 
p<0.01; AUC=0.87–0.96, p<0.01). The APSQ applied at step 
1 (triage) identified 57.1% (N=160) of the sample requiring 
progression to step 2 (screening). Overall, the APSQ performed 
well in case detection for the six screening instruments at step 
2 (table 1). The APSQ correctly detected all positive screened 
cases for the GAD-7, PHQ-9 and CAGE- AID, while only a 
small proportion of cases was misclassified for the AASQ (5%), 
AUDIT- C (16%) and BEDA- Q (11%).
DISCUSSION
In response to a recommendation of the International Olympic 
Committee consensus statement on mental health in elite athletes, 
the SMHAT-1 and SMHRT-1 were developed to provide tools to 
assess and manage mental health symptoms and disorders in elite 
athletes throughout their sporting career. For the SMHAT-1, the 
IOC MHWG strived to select existing validated screening question-
naires for mental health symptoms and disorders that were devel-
oped for and validated in an (elite) athlete population. However, 
such questionnaires are rather scarce. Within the SMHAT-1, only 
3 out of the 12 screening questionnaires are athlete- specific. One 
of them is the APSQ, which is used as triage to assess sport- related 
psychological distress.38 39 The APSQ was recently developed for 
and validated in professional athletes, focusing particularly on the 
sport environment. Therefore, it is possible that mental health 
symptoms and disorders that manifest outside the sport envi-
ronment might not be captured with this questionnaire. Another 
screening questionnaire developed for and validated in an (elite) 
athlete population is the BEDA- Q, which assesses the presence 
of disordered eating.55 However, the BEDA- Q has no established 
cut- off, and therefore the authors proposed a cut- off of 4 or 
more based on the data presented in this article. It is important 
to emphasise that a positive screening on any disorder- specific 
screening questionnaires does not automatically provide a diagnosis 
for the disorder, but it is a prompt for further clinical evaluation. 
For the other screening questionnaires that were developed for and 
validated in non- athlete populations, their psychometric properties 
(especially sensitivity and specificity) might differ when used in an 
(elite) athlete population.
The SMHAT-1 and SMHRT-1 are the first versions of the tools 
to identify elite athletes at risk for experiencing mental health 
symptoms and disorders. Analogous to sport concussion and 
its assessment (SCAT) and recognition (CRT) tools,11 the IOC 
MHWG intends to revise the SMHAT-1 and SMHRT-1 in the 
future as needed, concurrent with an anticipated updating of the 
International Olympic Committee consensus statement on mental 
health in elite athletes. Until then, the IOC MHWG recommends 
further validation of the SMHAT-1’s underlying screening ques-
tionnaires, and the analysis of practicality and utility in a variety 
of elite athlete populations across different sports and countries.
The SMHAT-1 should be part of a regular screening programme, 
in parallel with, for example, musculoskeletal and cardiovascular 
screening. As the use of the SMHAT-1 is likely to increase the 
number of referrals, it is important to have sport- specific mental 
health supports in place for the care of athletes. We strongly 
recommend collaboration between sport medicine physicians and 
mental health professionals (eg, psychologists and psychiatrists). 
Table 1 Misclassification of the APSQ at step 1 (triage) for six 
instruments at step 2 (screening)
Positive cases detected at 
step 1 (APSQ) and at step 2
Positive cases not detected at step 
1 (APSQ) but detected at step 2
GAD-7 N=18 (6%) N=0 (0%)
PHQ-9 N=24 (9%) N=0 (0%)
ASSQ N=61 (22%) N=14 (5%)
AUDIT- C N=88 (32%) N=44 (16%)
CAGE- AID N=5 (2%) N=0 (0%)
BEDA- Q N=77 (28%) N=32 (11%)
APSQ, Athlete Psychological Strain Questionnaire; ASSQ, Athlete Sleep Screening 
Questionnaire; AUDIT- C, Alcohol Use Disorders Identification Test Consumption; BEDA- Q, 
Brief Eating Disorder in Athletes Questionnaire; CAGE- AID, Cutting Down, Annoyance by 
Criticism, Guilty Feeling, and Eye- openers Adapted to Include Drugs; GAD-7, General Anxiety 
Disorder-7; N, number; PHQ-9, Patient Health Questionnaire-9.
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Furthermore, education about mental health symptoms and disor-
ders in elite athletes as well as the use of the SMHAT-1 has been 
developed by the IOC to improve the clinical competency of sports 
medicine physicians and other licensed/registered health profes-
sionals. Ideally this education should be embedded within their 
respective professional school curricula. For all other members 
of the athletes’ entourage, the SMHRT-1 can be used to increase 
focus on the mental health of elite athletes.
Several limitations of our approach should be acknowl-
edged. First, information gathered through questionnaires in the 
SMHAT-1 remains self- reported and thus its external validity 
depends on the accuracy of the respondent’s answers. Second, 
some of the existing validated screening questionnaires selected 
for the SMHAT-1 were developed for and validated in non- athlete 
populations. Third, the triage step in the SMHAT-1 relies on the 
APSQ. While this questionnaire includes athlete- specific questions 
within an athletic context and has been validated in several popu-
lations of elite athletes, the APSQ (as most other existing screening 
instruments) does not reach 100% sensitivity and 100% specificity. 
This implies the possibility of obtaining false negatives and false 
positives in the triage step of the SMHAT-1. Fourth, the SMHAT-1 
should be used by sports medicine physicians and other licensed/
registered health professionals, while subsequent referral to a 
clinical psychologist or psychiatrist in particular cases is advised. 
In some countries, such a referral might not always be possible. 
Fifth, the SMHAT-1 and SMHRT-1 are currently available only 
in English. Translations (and related validation studies) should be 
made available in the future, which aligns with the ambition of 
the IOC. Lastly, the SMHAT-1 was preliminarily validated among 
professional footballers (men and women) from one country. 
Future validation studies should be conducted among athletes from 
other sport disciplines and cultures, while the use and application 
of the SMHAT-1 longitudinally should be evaluated. This is the 
intention of the IOC and its MHWG.
CONCLUSION
Following the International Olympic Committee consensus state-
ment on mental health in elite athletes, we developed the SMHAT-1 
and SMHRT-1 to identify elite athletes at risk for or already expe-
riencing mental health symptoms and/or disorders. These tools 
should facilitate the timely referral of those athletes in need for 
appropriate support and treatment. This initiative aligns with the 
IOC’s commitment to improve the mental health of elite athletes.
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What are the findings?
 ► The International Olympic Committee Sport Mental Health 
Assessment Tool 1 (IOC SMHAT-1) was developed to identify 
elite athletes at risk for or already experiencing mental health 
symptoms and disorders, to facilitate timely referral of those 
in need to adequate support and treatment.
 ► IOC SMHAT-1 should be used by sports medicine physicians 
and other licensed/registered health professionals during 
the precompetition period (ie, ideally a few weeks after 
the start of sport training) and when any significant event 
for an athlete occurs (eg, major injury/illness, unexplained 
performance concern, end of competitive cycle, suspected 
harassment/abuse, adverse life event and transitioning out of 
sport).
 ► The IOC Sport Mental Health Recognition Tool 1 was 
developed for athletes, coaches, family members and all 
other members of the athlete’s entourage to facilitate early 
detection of mental health symptoms in athletes to promote 
help- seeking for those in need.
How might it impact on clinical practice in the future?
 ► The use of the SMHAT-1 by licensed/registered health 
professionals (especially sports medicine physicians) and the 
SMHRT-1 by athletes and all members of their entourage 
should enable the identification of elite athletes at risk for 
experiencing mental health symptoms and disorders and 
facilitate the timely referral of those athletes in need for 
appropriate support and treatment.
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